Optimizing treatment for nasal NK T-cell lymphoma.
Authors:
- 11 August 2016
- journal article
- editorial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 57 (11) , 2487-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II studyAnnals of Hematology, 2014
- Management of Advanced NK/T-Cell LymphomaCurrent Hematologic Malignancy Reports, 2014
- How I treat NK/T-cell lymphomasBlood, 2013
- Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal typeBlood Research, 2013
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study GroupBlood, 2012
- Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal typeLeukemia & Lymphoma, 2011
- Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphomaMedical Oncology, 2009
- Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive TractInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell LymphomaJournal of Clinical Oncology, 2006